Organovo Logo
Search
Skip to content
  • About
    • About Organovo
    • History
    • Management Team
    • Board of Directors
    • News
      • Press Releases
      • Media Coverage
      • Events
      • Media Library
    • Contact
      • Tissue & Service Inquiries
      • Partnership Inquiries
      • Investor Relations
      • Media Inquiries
  • Science & Technology
    • Bioprinted Human Tissue
      • Living Human Tissue
      • Architecturally Correct Tissue
      • Bioprinting Advantages
      • Scientific Origins
    • Bioprinting Process
    • Publications
  • Tissues & Services
    • exVive3D™ Human Tissue Models & Services for Research
      • 3D Human Liver Tissue Testing Services
      • exVive3D™ Liver Tissue Performance
    • 3D Human Tissues for Medical Research & Therapeutics
  • Partnership
    • Custom Tissue Partnerships
      • Tissue Partnership Process
    • Technology Access Partnerships
  • Careers
  • Investors
    • Investor Overview
    • Investor Kit
    • Stock Quote & Chart
      • Historical Stock Quote
      • Investment Calculator
    • Analyst Coverage
    • Press Releases
    • Event Calendar
    • SEC Filings
      • Annual Reports & Proxies
    • Quarterly Results
    • Corporate Governance
      • Management Team
      • Board of Directors
      • Committee Composition
    • Frequently Asked Questions
    • Investor Alerts
    • Investor Contacts
  • Investor Overview
  • Investor Kit
  • Stock Quote & Chart
    • Historical Stock Quote
    • Investment Calculator
  • Analyst Coverage
  • Press Releases
  • Event Calendar
  • SEC Filings
    • Annual Reports & Proxies
  • Quarterly Results
  • Corporate Governance
    • Management Team
    • Board of Directors
    • Committee Composition
  • Frequently Asked Questions
  • Investor Alerts
  • Investor Contacts

2018 Press Releases

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014 | 2013
04/16/18
Organovo Achieves Key Development Milestones for Its Liver Disease and Intestinal Tissue Models
04/12/18
Organovo Presents Data on Modeling Liver Disease Using 3D Bioprinted Human Liver Tissue at The International Liver Congress™
03/26/18
Organovo Division Samsara Sciences Announces Multi-Year Supply Agreement With Lonza Bioscience Solutions
03/15/18
Organovo to Present at H.C. Wainwright Nash Investor Conference
03/08/18
Organovo to Present at 30th Annual ROTH Conference
02/08/18
Organovo Announces Fiscal Third-Quarter 2018 Results; Company Updates Full-Year Fiscal 2018 Outlook
01/18/18
Organovo Announces Release Date for Fiscal Third-Quarter 2018 Financial Results
Print Page Print Page | E-mail Page Email Page | RSS Feeds RSS Feeds | IR Contacts Investor Contacts | Financial Tear Sheet Financial Tear Sheet
© 2017 Organovo Holdings Inc. 6275 Nancy ridge drive, suite 110. San diego, CA 92121
  • Privacy Policy
  • Contact
  • Site Map
MENU
  • About
    • About Organovo
    • History
    • Management Team
    • Board of Directors
    • News
      • Press Releases
      • Media Coverage
      • Events
      • Media Library
    • Contact
      • General Inquiry/Location/Map
      • Tissue & Service Inquiries
      • Partnership Inquiries
      • Investor Relations
      • Media Inquiries
  • Science & Technology
    • Bioprinted Human Tissue
      • Living Human Tissue
      • Architecturally Correct Tissue
      • Bioprinting Advantages
      • Scientific Origins
    • Bioprinting Process
    • Publications
  • Tissues & Services
    • exVive3D™ Human Tissue Models & Services for Research
      • 3D Human Liver Tissue Testing Services
      • exVive3D™ Liver, Tissue Performance
    • 3D Human Tissues for Medical Research & Therapeutics
  • Partnership
    • Custom Tissue Partnerships
      • Tissue Partnership Process
    • Technology Access Partnerships
  • Careers
  • Investors
    • Investor Overview
    • Investor Kit
    • Stock Quote & Chart
      • Historical Stock Quote
      • Investment Calculator
    • Analyst Coverage
    • Press Releases
    • Event Calendar
    • SEC Filings
      • Annual Reports & Proxies
    • Quarterly Results
    • Corporate Governance
      • Management Team
      • Board of Directors
      • Committee Composition
    • Frequently Asked Questions
    • Investor Alerts
    • Investor Contacts